AU2001248833A1 - Stable liquid preparation - Google Patents

Stable liquid preparation

Info

Publication number
AU2001248833A1
AU2001248833A1 AU2001248833A AU4883301A AU2001248833A1 AU 2001248833 A1 AU2001248833 A1 AU 2001248833A1 AU 2001248833 A AU2001248833 A AU 2001248833A AU 4883301 A AU4883301 A AU 4883301A AU 2001248833 A1 AU2001248833 A1 AU 2001248833A1
Authority
AU
Australia
Prior art keywords
liquid preparation
stable liquid
stable
preparation
liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001248833A
Other languages
English (en)
Inventor
Masanori Araki
Azusa Matsukawa
Hiroaki Nakagami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Publication of AU2001248833A1 publication Critical patent/AU2001248833A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AU2001248833A 2000-04-24 2001-04-23 Stable liquid preparation Abandoned AU2001248833A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000-127622 2000-04-24
JP2000127622 2000-04-24
JP2000149812 2000-05-17
JP2000-149812 2000-05-17
PCT/JP2001/003457 WO2001080858A1 (fr) 2000-04-24 2001-04-23 Preparation liquide stable

Publications (1)

Publication Number Publication Date
AU2001248833A1 true AU2001248833A1 (en) 2001-11-07

Family

ID=26590975

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001248833A Abandoned AU2001248833A1 (en) 2000-04-24 2001-04-23 Stable liquid preparation

Country Status (20)

Country Link
US (1) US7304075B2 (ja)
EP (1) EP1277471B1 (ja)
JP (1) JP5027975B2 (ja)
KR (1) KR100858228B1 (ja)
CN (1) CN1326524C (ja)
AR (1) AR028028A1 (ja)
AT (1) ATE396729T1 (ja)
AU (1) AU2001248833A1 (ja)
BR (1) BR0110290A (ja)
CA (1) CA2406849C (ja)
DE (1) DE60134221D1 (ja)
DK (1) DK1277471T3 (ja)
ES (1) ES2305065T3 (ja)
HK (1) HK1050326A1 (ja)
MX (1) MXPA02010497A (ja)
NO (1) NO323810B1 (ja)
PT (1) PT1277471E (ja)
RU (1) RU2295342C2 (ja)
TW (1) TWI280131B (ja)
WO (1) WO2001080858A1 (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004011001A1 (ja) 2002-07-31 2004-02-05 Senju Pharmaceutical Co., Ltd. 水性液剤および光安定化された水性液剤
US8877168B1 (en) 2002-07-31 2014-11-04 Senju Pharmaceuticals Co., Ltd. Aqueous liquid preparations and light-stabilized aqueous liquid preparations
JP2006151808A (ja) * 2002-12-24 2006-06-15 Dai Ichi Seiyaku Co Ltd 抗菌性水性製剤
EP2055304A1 (en) 2006-08-25 2009-05-06 Astellas Pharma Inc. Stabilized pharmaceutical composition
JP5258331B2 (ja) * 2008-03-03 2013-08-07 ロート製薬株式会社 光安定性が改善されたニューキノロン系抗菌剤含有医薬組成物
WO2010146478A1 (en) * 2009-05-08 2010-12-23 Ranbaxy Laboratories Limited Parenteral composition comprising a fluoroquinolone compound and a nitroimidazole compound
CN101690712B (zh) * 2009-08-25 2011-06-15 武汉武药科技有限公司 一种西他沙星滴眼剂及其制备方法
CN103087042B (zh) * 2012-03-09 2015-02-18 南京优科生物医药有限公司 西他沙星的盐及制药用途
NZ703528A (en) * 2012-06-27 2016-08-26 Takeda Pharmaceutical Liquid preparations of amines and organic acids stabilized by salts
US9320740B2 (en) 2013-03-15 2016-04-26 Merck Sharp & Dohme Corp. Ceftolozane-tazobactam pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
MX2020004205A (es) 2013-03-15 2021-11-16 Merck Sharp & Dohme Llc Composiciones antibioticas de ceftolozano.
AU2014233637A1 (en) 2013-09-09 2015-03-26 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN103622973B (zh) * 2013-12-02 2016-05-11 广东恒诚制药有限公司 一种复方醋酸曲安奈德溶液的制备方法
AT524927A1 (de) * 2021-04-07 2022-10-15 Engel Austria Gmbh Plastifiziereinheit für eine Formgebungsmaschine und Verfahren zum Betreiben einer solchen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3537761A1 (de) 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
IL90062A (en) * 1988-04-27 1994-10-07 Daiichi Seiyaku Co History of pyridonecarboxylic acid, their preparation and pharmaceutical preparations containing them
CA2053926A1 (en) 1989-04-28 1990-10-29 Genkichi Ohta Anti-hiv agent
RU2044544C1 (ru) 1989-04-28 1995-09-27 Дайити Фармасьютикал Ко., Лтд Композиция против вируса иммунодефицита человека

Also Published As

Publication number Publication date
AR028028A1 (es) 2003-04-23
HK1050326A1 (en) 2003-06-20
BR0110290A (pt) 2003-02-18
DE60134221D1 (de) 2008-07-10
NO20025081L (no) 2002-12-23
CN1326524C (zh) 2007-07-18
KR100858228B1 (ko) 2008-09-12
KR20020089523A (ko) 2002-11-29
US7304075B2 (en) 2007-12-04
CA2406849A1 (en) 2002-10-21
CA2406849C (en) 2007-10-23
PT1277471E (pt) 2008-08-26
NO20025081D0 (no) 2002-10-22
CN1438888A (zh) 2003-08-27
WO2001080858A1 (fr) 2001-11-01
RU2002128631A (ru) 2004-03-27
US20030139436A1 (en) 2003-07-24
ES2305065T3 (es) 2008-11-01
NO323810B1 (no) 2007-07-09
ATE396729T1 (de) 2008-06-15
EP1277471A1 (en) 2003-01-22
TWI280131B (en) 2007-05-01
DK1277471T3 (da) 2008-08-11
RU2295342C2 (ru) 2007-03-20
EP1277471A4 (en) 2006-04-12
JP5027975B2 (ja) 2012-09-19
MXPA02010497A (es) 2003-05-14
EP1277471B1 (en) 2008-05-28

Similar Documents

Publication Publication Date Title
AU2001251485A1 (en) Container
AU2001258096A1 (en) Container
AU2001296869A1 (en) Container
AU2001267516A1 (en) Container
AU2001295657A1 (en) Formulation containing wax-esters
AU2001273423A1 (en) Liquid applicator
AU2001263839A1 (en) Liquid formulations
AU2001251275A1 (en) Liquid dispenser
AU2001262691A1 (en) Cosmetic preparation
AU2001231088A1 (en) Mutli-purpose container
AU6383901A (en) Liquid formulations
AU2002224922A1 (en) Liquid yeast compositions
AU2001248833A1 (en) Stable liquid preparation
AU2001269441A1 (en) Container
AU2001238138A1 (en) Body-cooling container
AU2001274523A1 (en) Liquid applicator
AU2001256714A1 (en) Water-based liquid preparation
AU2002212234A1 (en) Stable ophthalmic preparation
AU2001287993A1 (en) Container
AU2001256877A1 (en) Liquid dispenser
AUPR099200A0 (en) New formulation
AU2001225166A1 (en) Liquid filter
AU2001229007A1 (en) Liquid heater
AUPQ645600A0 (en) Liquid metering
AU4657201A (en) Liquid trap